Innovative Medicines Initiative (imi)
About Innovative Medicines Initiative
The Innovative Medicines Initiative (imi) is Europe's largest public-private initiative for the pharmaceutical innovation with the participation of the European Union and EFPIA. IMI brings together companies from industry and research to accelerate the accelerate the discovery and development of better and safer medicines for patients safer medicines for patients and to help improve the competitiveness of European products. products. The initiative focuses on the safety of products products, the promotion of young researchers and the expansion of the international knowledge network.
Note: This article has been translated using a computer system without human intervention. LUMITOS offers these automatic translations to present a wider range of company presentation. Since this article has been translated with automatic translation, it is possible that it contains errors in vocabulary, syntax or grammar. The original article in German can be found here.
- Industry : Pharma
